Literature DB >> 17088550

Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.

Jiri Kohoutek1, Dalibor Blazek, B Matija Peterlin.   

Abstract

The class II transactivator (CIITA) is the master integrator of expression of MHC class II genes. It interacts with variety of basal transcription factors to initiate and elongate transcription of these genes. Among others, it recruits positive transcription elongation factor b (P-TEFb) to MHC class II promoters. In cells, P-TEFb is found in small active or large inactive complexes. The large complex is composed of P-TEFb, 7SK small nuclear RNA, and hexamethylene bisacetamide-inducible protein 1 (Hexim1). The present study identifies Hexim1 as a potent inhibitor of CIITA-mediated transcription. Not only the exogenously expressed but also IFN-gamma-induced CIITA was inhibited by Hexim1. This inhibition did not result from an association between Hexim1 and CIITA but depended on the intact Cyclin T1-binding domain in Hexim1. Importantly, Hexim1 sequestered P-TEFb from CIITA, as documented by binding competition and ChIP assays. Conversely, the depletion of Hexim1 from cells by siRNA increased CIITA-mediated transcription. Thus, modulating ratios between active and inactive P-TEFb complexes is an additional mechanism of regulating transcriptional activators such as CIITA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17088550      PMCID: PMC1859933          DOI: 10.1073/pnas.0603079103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  The bare lymphocyte syndrome and the regulation of MHC expression.

Authors:  W Reith; B Mach
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Generation of deletion and point mutations with one primer in a single cloning step.

Authors:  O Makarova; E Kamberov; B Margolis
Journal:  Biotechniques       Date:  2000-11       Impact factor: 1.993

Review 3.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

4.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

5.  Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.

Authors:  K Nickerson; T J Sisk; N Inohara; C S Yee; J Kennell; M C Cho; P J Yannie; G Nunez; C H Chang
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

6.  Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P-TEFb.

Authors:  Matjaz Barboric; Jirí Kohoutek; Jason P Price; Dalibor Blazek; David H Price; B Matija Peterlin
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

7.  BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells.

Authors:  J F Piskurich; K I Lin; Y Lin; Y Wang; J P Ting; K Calame
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

8.  Constitutive expression of MHC class II genes in melanoma cell lines results from the transcription of class II transactivator abnormally initiated from its B cell-specific promoter.

Authors:  V Deffrennes; J Vedrenne; M C Stolzenberg; J Piskurich; G Barbieri; J P Ting; D Charron; C Alcaïde-Loridan
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

9.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection.

Authors:  S Kanazawa; T Okamoto; B M Peterlin
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

10.  Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb.

Authors:  Dalibor Blazek; Matjaz Barboric; Jiri Kohoutek; Irena Oven; B Matija Peterlin
Journal:  Nucleic Acids Res       Date:  2005-12-23       Impact factor: 16.971

View more
  8 in total

1.  Tissue- and context-dependent modulation of hormonal sensitivity of glucocorticoid-responsive genes by hexamethylene bisacetamide-inducible protein 1.

Authors:  Noriaki Shimizu; Noritada Yoshikawa; Tadashi Wada; Hiroshi Handa; Motoaki Sano; Keiichi Fukuda; Makoto Suematsu; Takashi Sawai; Chikao Morimoto; Hirotoshi Tanaka
Journal:  Mol Endocrinol       Date:  2008-09-18

2.  hLARP7 C-terminal domain contains an xRRM that binds the 3' hairpin of 7SK RNA.

Authors:  Catherine D Eichhorn; Rahul Chug; Juli Feigon
Journal:  Nucleic Acids Res       Date:  2016-09-26       Impact factor: 16.971

3.  APOBEC3 proteins inhibit LINE-1 retrotransposition in the absence of ORF1p binding.

Authors:  Nika Lovsin; B Matija Peterlin
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

4.  Cyclin T2 is essential for mouse embryogenesis.

Authors:  Jiri Kohoutek; Qintong Li; Dalibor Blazek; Zeping Luo; Huimin Jiang; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

5.  AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells.

Authors:  Irena Oven; Nadezda Brdicková; Jiri Kohoutek; Tomaz Vaupotic; Mojca Narat; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

6.  Control of HIV latency by epigenetic and non-epigenetic mechanisms.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Curr HIV Res       Date:  2011-12-01       Impact factor: 1.581

7.  A structure-based mechanism for displacement of the HEXIM adapter from 7SK small nuclear RNA.

Authors:  Vincent V Pham; Michael Gao; Jennifer L Meagher; Janet L Smith; Victoria M D'Souza
Journal:  Commun Biol       Date:  2022-08-15

8.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.